Current challenges in the pharmacological management of thyroid dysfunction in pregnancy

References

• Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31(5):702–755.
   PubMed Web of Science ®Google Scholar
• Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29(1):76–131.
   PubMed Web of Science ®Google Scholar
• Okosieme OE, Marx H, Lazarus JH. Medical management of thyroid dysfunction in pregnancy and the postpartum. Expert Opin Pharmacother. 2008;9(13):2281–2293.
   PubMed Web of Science ®Google Scholar
• Davis LE, Lucas MJ, Hankins GD, et al. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol. 1989;160(1):63–70.
   PubMed Web of Science ®Google Scholar
• Taylor PN, Minassian C, Rehman A, et al. TSH levels and risk of miscarriage in women on long-term levothyroxine: a community-based study. J Clin Endocrinol Metab. 2014;99(10):3895–3902.
   PubMed Web of Science ®Google Scholar
• Davis LE, Leveno KJ, Cunningham FG. Hypothyroidism complicating pregnancy. Obstet Gynecol. 1988;72(1):108–112.
   PubMed Web of Science ®Google Scholar
• Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005;105(2):239–245.
   PubMed Web of Science ®Google Scholar
• Abalovich M, Gutierrez S, Alcaraz G, et al. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12(1):63–68.
   PubMed Web of Science ®Google Scholar
• Klein RZ, Haddow JE, Faix JD, et al. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf). 1991;35(1):41–46.
   PubMed Web of Science ®Google Scholar
• Moreno-Reyes R, Glinoer D, Van Oyen H, et al. High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: a population-based study. J Clin Endocrinol Metab. 2013;98(9):3694–3701.
   PubMed Web of Science ®Google Scholar
• Roberts CG, Ladenson PW. Hypothyroidism. Lancet. 2004;363(9411):793–803.
   PubMed Web of Science ®Google Scholar
• De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(8):2543–2565.
   PubMed Web of Science ®Google Scholar
• Vaidya B, Anthony S, Bilous M, et al. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? J Clin Endocrinol Metab. 2007;92(1):203–207.
   PubMed Web of Science ®Google Scholar
• Chang DL, Leung AM, Braverman LE, et al. Thyroid testing during pregnancy at an academic Boston Area Medical Center. J Clin Endocrinol Metab. 2011;96(9):E1452- E6.
   PubMed Web of Science ®Google Scholar
• Vaidya B, Hubalewska-Dydejczyk A, Laurberg P, et al. Treatment and screening of hypothyroidism in pregnancy: results of a European survey. Eur J Endocrinol. 2012;166(1):49–54.
   PubMed Web of Science ®Google Scholar
• Okosieme O, Gilbert J, Abraham P, et al. Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee. Clin Endocrinol (Oxf). 2016;84:799–808.
   PubMed Web of Science ®Google Scholar
• Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21(10):1081–1125.
   PubMed Web of Science ®Google Scholar
• Lazarus J, Brown RS, Daumerie C, et al. 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J. 2014;3(2):76–94.
   PubMedGoogle Scholar
• Brenta G, Vaisman M, Sgarbi JA, et al. Clinical practice guidelines for the management of hypothyroidism. Arq Bras Endocrinol Metabol. 2013;57(4):265–291.
   PubMedGoogle Scholar
• ACOG. Practice bulletin no. 148: thyroid disease in pregnancy. Obstet Gynecol. 2015;125(4):996–1005.
   PubMedGoogle Scholar
• Eligar V, Taylor PN, Okosieme OE, et al. Thyroxine replacement: a clinical endocrinologist’s viewpoint. Ann Clin Biochem. 2016;53(Pt 4):421–433.
   PubMed Web of Science ®Google Scholar
• Okosieme OE. Thyroid hormone replacement: current status and challenges. Expert Opin Pharmacother. 2011;12(15):2315–2328.
   PubMed Web of Science ®Google Scholar
• Yassa L, Marqusee E, Fawcett R, et al. Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. J Clin Endocrinol Metab. 2010;95(7):3234–3241.
   PubMed Web of Science ®Google Scholar
• Vadiveloo T, Mires GJ, Donnan PT, et al. Thyroid testing in pregnant women with thyroid dysfunction in Tayside, Scotland: the thyroid epidemiology, audit and research study (TEARS). Clin Endocrinol (Oxf). 2013;78(3):466–471.
   PubMed Web of Science ®Google Scholar
• Khan I, Witczak JK, Hadjieconomou S, et al. Preconception thyroid-stimulating hormone and pregnancy outcomes in women with hypothyroidism. Endocr Pract. 2013;19(4):656–662.
   PubMed Web of Science ®Google Scholar
• Abalovich M, Alcaraz G, Kleiman-Rubinsztein J, et al. The relationship of preconception thyrotropin levels to requirements for increasing the levothyroxine dose during pregnancy in women with primary hypothyroidism. Thyroid. 2010;20(10):1175–1178.
   PubMed Web of Science ®Google Scholar
• Rotondi M, Mazziotti G, Sorvillo F, et al. Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy. Eur J Endocrinol. 2004;151(6):695–700.
   PubMed Web of Science ®Google Scholar
• Lazarus JH, Bestwick JP, Channon S, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med. 2012;366(6):493–501.
   PubMed Web of Science ®Google Scholar
• Korevaar TI, Muetzel R, Medici M, et al. Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study. Lancet Diabetes Endocrinol. 2016;4(1):35–43.
   PubMed Web of Science ®Google Scholar
• Pharoah PO, Buttfield IH, Hetzel BS. Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet. 1971;1(7694):308–310.
   PubMed Web of Science ®Google Scholar
• Brent GA. Maternal thyroid function: interpretation of thyroid function tests in pregnancy. Clin Obstet Gynecol. 1997;40(1):3–15.
   PubMed Web of Science ®Google Scholar
• Panesar NS, Li CY, Rogers MS. Reference intervals for thyroid hormones in pregnant Chinese women. Ann Clin Biochem. 2001;38(Pt 4):329–332.
   PubMed Web of Science ®Google Scholar
• Soldin OP. Thyroid function testing in pregnancy and thyroid disease: trimester-specific reference intervals. Ther Drug Monit. 2006;28(1):8–11.
   PubMed Web of Science ®Google Scholar
• Bocos-Terraz JP, Izquierdo-Alvarez S, Bancalero-Flores JL, et al. Thyroid hormones according to gestational age in pregnant Spanish women. BMC Research Notes. 2009;2:237.
   PubMedGoogle Scholar
• Stricker R, Echenard M, Eberhart R, et al. Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur J Endocrinol. 2007;157(4):509–514.
   PubMed Web of Science ®Google Scholar
• Medici M, Korevaar TI, Visser WE, et al. Thyroid function in pregnancy: what is normal? Clin Chem. 2015;61(5):704–713.
   PubMed Web of Science ®Google Scholar
• Li C, Shan Z, Mao J, et al. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women? J Clin Endocrinol Metab. 2014;99(1):73–79.
   PubMed Web of Science ®Google Scholar
• Marwaha RK, Chopra S, Gopalakrishnan S, et al. Establishment of reference range for thyroid hormones in normal pregnant Indian women. Bjog. 2008;115(5):602–606.
   PubMed Web of Science ®Google Scholar
• Moon HW, Chung HJ, Park CM, et al. Establishment of trimester-specific reference intervals for thyroid hormones in Korean pregnant women. Ann Lab Med. 2015;35(2):198–204.
   PubMed Web of Science ®Google Scholar
• Korevaar TI, Medici M, De Rijke YB, et al. Ethnic differences in maternal thyroid parameters during pregnancy: the Generation R study. J Clin Endocrinol Metab. 2013;98(9):3678–3686.
   PubMed Web of Science ®Google Scholar
• Akarsu S, Akbiyik F, Karaismailoglu E, et al. Gestation specific reference intervals for thyroid function tests in pregnancy. Clin Chem Lab Med. 2016;54:1377–1383.
   Google Scholar
• Bestwick JP, John R, Maina A, et al. Thyroid stimulating hormone and free thyroxine in pregnancy: expressing concentrations as multiples of the median (MoMs). Clin Chim Acta. 2014;430:33–37.
   PubMed Web of Science ®Google Scholar
• Shields BM, Knight BA, Hill AV, et al. Five-year follow-up for women with subclinical hypothyroidism in pregnancy. J Clin Endocrinol Metab. 2013;98(12):E1941- E5.
   PubMed Web of Science ®Google Scholar
• Stagnaro-Green A, Chen X, Bogden JD, et al. The thyroid and pregnancy: a novel risk factor for very preterm delivery. Thyroid. 2005;15(4):351–357.
   PubMed Web of Science ®Google Scholar
• Glinoer D, Soto MF, Bourdoux P, et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab. 1991;73(2):421–427.
   PubMed Web of Science ®Google Scholar
• Allan WC, Haddow JE, Palomaki GE, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen. 2000;7(3):127–130.
   PubMed Web of Science ®Google Scholar
• Benhadi N, Wiersinga WM, Reitsma JB, et al. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol. 2009;160(6):985–991.
   PubMed Web of Science ®Google Scholar
• Chan S, Boelaert K. Optimal management of hypothyroidism, hypothyroxinaemia and euthyroid TPO antibody positivity preconception and in pregnancy. Clin Endocrinol (Oxf). 2015;82(3):313–326.
   PubMed Web of Science ®Google Scholar
• Negro R, Schwartz A, Gismondi R, et al. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab. 2010;95(9):E44- E8.
   PubMed Web of Science ®Google Scholar
• Cleary-Goldman J, Malone FD, Lambert-Messerlian G, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol. 2008;112(1):85–92.
   PubMed Web of Science ®Google Scholar
• Bryant SN, Nelson DB, McIntire DD, et al. An analysis of population-based prenatal screening for overt hypothyroidism. Am J Obstet Gynecol. 2015;213(4):565e1–6.
   Web of Science ®Google Scholar
• Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341(8):549–555.
   PubMed Web of Science ®Google Scholar
• Negro R, Schwartz A, Gismondi R, et al. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab. 2010;95(4):1699–1707.
   PubMed Web of Science ®Google Scholar
• Negro R, Schwartz A, Stagnaro-Green A. Impact of levothyroxine in miscarriage and preterm delivery rates in first trimester thyroid antibody-positive women with TSH<2.5mIU/L. J Clin Endocrinol Metab. 2016;101:3685–3690.
   PubMed Web of Science ®Google Scholar
• Casey B. 2: effect of treatment of maternal subclinical hypothyroidism or hypothyroxinemia on IQ in offspring. Am J Obstetrics Gynecol. 2016;214(1):S2.
   Web of Science ®Google Scholar
• Moleti M, Trimarchi F, Vermiglio F. Doubts and concerns about isolated maternal hypothyroxinemia. J Thyroid Res. 2011;2011:463029.
   PubMedGoogle Scholar
• Casey BM, Dashe JS, Spong CY, et al. Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol. 2007;109(5):1129–1135.
   PubMed Web of Science ®Google Scholar
• Korevaar TI, Schalekamp-Timmermans S, De Rijke YB, et al. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study. J Clin Endocrinol Metab. 2013;98(11):4382–4390.
   PubMed Web of Science ®Google Scholar
• Pop VJ, Brouwers EP, Vader HL, et al. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf). 2003;59(3):282–288.
   PubMed Web of Science ®Google Scholar
• Li Y, Shan Z, Teng W, et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months. Clin Endocrinol (Oxf). 2010;72(6):825–829.
   PubMed Web of Science ®Google Scholar
• Chevrier J, Harley KG, Kogut K, et al. Maternal thyroid function during the second half of pregnancy and child neurodevelopment at 6, 12, 24, and 60 months of age. J Thyroid Res. 2011;2011:426427.
   PubMedGoogle Scholar
• Craig WY, Allan WC, Kloza EM, et al. Mid-gestational maternal free thyroxine concentration and offspring neurocognitive development at age two years. J Clin Endocrinol Metab. 2012;97(1):E22–8.
   PubMed Web of Science ®Google Scholar
• Carlé A, Pedersen IB, Knudsen N, et al. Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. Eur J Endocrinol. 2011;164(5):801–809.
   PubMed Web of Science ®Google Scholar
• Weetman AP. Graves’ disease. N Engl J Med. 2000;343(17):1236–1248.
   PubMed Web of Science ®Google Scholar
• Okosieme OE, Lazarus JH. Important considerations in the management of Graves’ disease in pregnant women. Expert Rev Clin Immunol. 2015;11(8):947–957.
   PubMed Web of Science ®Google Scholar
• McKenzie JM, Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid. 1992;2(2):155–159.
   PubMed Web of Science ®Google Scholar
• Ross DS, Burch HB, Cooper DS, et al. American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26:1343–1421.
   Google Scholar
• Glinoer D. Thyroid hyperfunction during pregnancy. Thyroid. 1998;8(9):859–864.
   PubMed Web of Science ®Google Scholar
• Zakarija M, McKenzie JM. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves’ disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab. 1983;57(5):1036–1040.
   PubMed Web of Science ®Google Scholar
• Evans C, Gregory JW, Barton J, et al. Transient congenital hypothyroidism due to thyroid-stimulating hormone receptor blocking antibodies: a case series. Ann Clin Biochem. 2011;48:386–390.
   PubMed Web of Science ®Google Scholar
• Momotani N, Noh J, Oyanagi H, et al. Antithyroid drug therapy for Graves’ disease during pregnancy optimal regimen for fetal thyroid status. N Engl J Med. 1986;315(1):24–28.
   PubMed Web of Science ®Google Scholar
• Mestman JH. Hyperthyroidism in pregnancy. Curr Opin Endocrinol Diabetes Obes. 2012;19(5):394–401.
   PubMed Web of Science ®Google Scholar
• Lee YS, Loke KY, Ng SC, et al. Maternal thyrotoxicosis causing central hypothyroidism in infants. J Paediatr Child Health. 2002;38:206–208. Australia.
   PubMed Web of Science ®Google Scholar
• Polak M, Le Gac I, Vuillard E, et al. Fetal and neonatal thyroid function in relation to maternal Graves’ disease. Best Pract Res Clin Endocrinol Metab. 2004;18:289–302; England.
   PubMed Web of Science ®Google Scholar
• Bahn Chair RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593–646.
   PubMed Web of Science ®Google Scholar
• Laurberg P, Nygaard B, Glinoer D, et al. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol. 1998;139(6):584–586.
   PubMed Web of Science ®Google Scholar
• Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352(9):905–917.
   PubMed Web of Science ®Google Scholar
• Marchant B, Brownlie BE, Hart DM, et al. The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab. 1977;45(6):1187–1193.
   PubMed Web of Science ®Google Scholar
• Mortimer RH, Cannell GR, Addison RS, et al. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab. 1997;82(9):3099–3102.
   PubMed Web of Science ®Google Scholar
• Momotani N, Noh JY, Ishikawa N, et al. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves’ hyperthyroidism. J Clin Endocrinol Metab. 1997;82(11):3633–3636.
   PubMed Web of Science ®Google Scholar
• Taylor PN, Vaidya B. Side effects of anti-thyroid drugs and their impact on the choice of treatment for thyrotoxicosis in pregnancy. Eur Thyroid J. 2012;1(3):176–185.
   PubMedGoogle Scholar
• Yoshihara A, Noh JY, Watanabe N, et al. Substituting potassium iodide for methimazole as the treatment for Graves’ disease during the first trimester may reduce the incidence of congenital anomalies: a retrospective study at a single medical institution in Japan. Thyroid. 2015;25(10):1155–1161.
   PubMed Web of Science ®Google Scholar
• Calhoun DA, Rosa C, Christensen RD. Transplacental passage of recombinant human granulocyte colony-stimulating factor in women with an imminent preterm delivery. Am J Obstet Gynecol. 1996;174(4):1306–1311.
   PubMed Web of Science ®Google Scholar
• Bahn RS, Burch HS, Cooper DS, et al. The role of propylthiouracil in the management of Graves’ disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid. 2009;19(7):673–674.
   PubMedGoogle Scholar
• Cooper DS, Rivkees SA. Putting propylthiouracil in perspective. J Clin Endocrinol Metab. 2009;94(6):1881–1882.
   PubMed Web of Science ®Google Scholar
• Hayashida CY, Duarte AJ, Sato AE, et al. Neonatal hepatitis and lymphocyte sensitization by placental transfer of propylthiouracil. J Endocrinol Invest. 1990;13(11):937–941.
   PubMed Web of Science ®Google Scholar
• Milham JSEW. Maternal methimazole and congenital defects in children. Clin Mol Teratology. 1972;5(1):125.
   Google Scholar
• Clementi M, Di Gianantonio E, Pelo E, et al. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet. 1999;83(1):43–46.
   PubMed Web of Science ®Google Scholar
• Karlsson FA, Axelsson O, Melhus H. Severe embryopathy and exposure to methimazole in early pregnancy. J Clin Endocrinol Metab. 2002;87(2):947–949.
   PubMed Web of Science ®Google Scholar
• Di Gianantonio E, Schaefer C, Mastroiacovo PP, et al. Adverse effects of prenatal methimazole exposure. Teratology. 2001;64(5):262–266.
   PubMedGoogle Scholar
• Clementi M, Di Gianantonio E, Cassina M, et al. Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab. 2010;95(11):E337- E41.
   PubMed Web of Science ®Google Scholar
• Yoshihara A, Noh J, Yamaguchi T, et al. Treatment of graves’ disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab. 2012;97:2396–2403; United States.
   PubMed Web of Science ®Google Scholar
• Andersen SL, Olsen J, Wu CS, et al. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J Clin Endocrinol Metab. 2013;98(11):4373–4381.
   PubMed Web of Science ®Google Scholar
• Andersen SL, Olsen J, Wu CS, et al. Severity of birth defects after propylthiouracil exposure in early pregnancy. Thyroid. 2014;24(10):1533–1540.
   PubMed Web of Science ®Google Scholar
• Chen CH, Xirasagar S, Lin CC, et al. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study. Bjog. 2011;118(11):1365–1373.
   PubMed Web of Science ®Google Scholar
• Gianetti E, Russo L, Orlandi F, et al. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy. J Endocrinol Invest. 2015;38(9):977–985.
   PubMed Web of Science ®Google Scholar
• Mandel SJ, Brent GA, Larsen PR. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid. 1994;4(1):129–133.
   PubMed Web of Science ®Google Scholar
• Momotani N, Ito K, Hamada N, et al. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol (Oxf). 1984;20(6):695–700.
   PubMed Web of Science ®Google Scholar
• Korelitz JJ, McNally DL, Masters MN, et al. Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid. 2013;23(6):758–765.
   PubMed Web of Science ®Google Scholar
• Pedersen RN, Calzolari E, Husby S, et al. Oesophageal atresia: prevalence, prenatal diagnosis and associated anomalies in 23 European regions. Arch Dis Child. 2012;97(3):227–232.
   PubMed Web of Science ®Google Scholar
• Case AP, Mitchell LE. Prevalence and patterns of choanal atresia and choanal stenosis among pregnancies in Texas, 1999-2004. Am J Med Genet A. 2011;155a(4):786–791.
   PubMed Web of Science ®Google Scholar
• Laurberg P, Andersen SL. Antithyroid drug use in pregnancy and birth defects: why some studies find clear associations, and some studies report none. Thyroid. 2015;25(11):1185–1190.
   PubMed Web of Science ®Google Scholar
• Li X, Liu GY, Ma JL, et al. Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis. Clinics (Sao Paulo, Brazil). 2015;70(6):453–459.
   PubMed Web of Science ®Google Scholar
• Li H, Zheng J, Luo J, et al. Congenital anomalies in children exposed to antithyroid drugs in-utero: a meta-analysis of cohort studies. Plos One. 2015;10(5):e0126610.
   PubMed Web of Science ®Google Scholar
• Wiles KS, Jarvis S, Nelson-Piercy C. Are we overtreating subclinical hypothyroidism in pregnancy? Bmj. 2015;351:h4726.
   PubMed Web of Science ®Google Scholar
• Laurberg P, Andersen SL. Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk? Eur J Endocrinol. 2014;171(1):R13- R20.
   PubMed Web of Science ®Google Scholar
• Zhou QLX, Wang C. Preconception thyroid screening and childhood neurocognitive function assessment at 1-year-old by Gesell Scale. Endocrine Reviews, 2015. 36(2):2015.
   Google Scholar
• Burch HB, Burman KD, Cooper DSA. 2011 survey of clinical practice patterns in the management of Graves’ disease. J Clin Endocrinol Metab. 2012;97(12):4549–4558.
   PubMed Web of Science ®Google Scholar